US FDA urged to withdraw "fundamentally-flawed" recalls and enhancements guideline
This article was originally published in SRA
Executive Summary
Efforts by the US Food and Drug Administration to clarify when safety-related changes to a medical device are regarded as a recall or an enhancements and when these changes should be reported have caused a stir within the medtech sector1,2.